Document is current
Any future updates will be listed below
-
Authors
Tessier, Camille E
Derrien, Jennifer
Dupuy, Aurore M M
Pelé, Thomas
Moquet, Martin
Roul, Julie
Douillard, Elise
El Harrif, Camille
Pinson, Xavier
Le Gallo, Matthieu
Godey, Florence
Tas, Patrick
Viel, Roselyne
Grasset, Eloïse
Prigent, Claude
Letouzé, Éric
Suzanne, Peggy https://orcid.org/0000-0002-6080-8306
Dallemagne, Patrick https://orcid.org/0000-0002-4845-615X
Campone, Mario
Weinberg, Robert A https://orcid.org/0000-0002-0895-3557
Lees, Jacqueline A https://orcid.org/0000-0001-9451-2194
Juin, Philippe P https://orcid.org/0000-0002-4997-3888
Guen, Vincent J https://orcid.org/0000-0003-2175-4066
-
Funding
Funding for this research was provided by:
Fondation de France
Conseil Régional des Pays de la Loire
Agence Nationale de la Recherche (I-site NExT)
Institut National Du Cancer (SIRIC ILIAD)
Institut National de la Santé et de la Recherche Médicale
Ligue Contre le Cancer
Institut de Cancérologie de l'Ouest
Cancéropôle Grand Ouest
Association Ruban Rose
- License Information
-
More Information
Article History
Received: 25 February 2025
Revised: 2 July 2025
Accepted: 9 July 2025
First Online: 26 August 2025
Disclosure and competing interests statement
: A Patient application #EP24199133.0 named INHIBITOR OF CILIOGENESIS FOR USE IN A METHOD OF PREVENTING THERAPEUTIC RESISTANCE IN CANCER was filed by Inserm Transfert.
